Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T11487
|
||||
Former ID |
TTDC00313
|
||||
Target Name |
Acetyl-CoA acetyltransferase, mitochondrial
|
||||
Gene Name |
ACAT1
|
||||
Synonyms |
Acetoacetyl-CoA thiolase; T2; ACAT1
|
||||
Target Type |
Discontinued
|
||||
Disease | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10: C11, C44, K75.9, M00-M25] | ||||
Function |
Plays a major role in ketone body metabolism.
|
||||
BioChemical Class |
Acyltransferase
|
||||
Target Validation |
T11487
|
||||
UniProt ID | |||||
EC Number |
EC 2.3.1.9
|
||||
Sequence |
MAVLAALLRSGARSRSPLLRRLVQEIRYVERSYVSKPTLKEVVIVSATRTPIGSFLGSLS
LLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCT TINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIV KDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTV TVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADA AKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVV LANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGAS AMLIQKL |
||||
Drugs and Mode of Action | |||||
Inhibitor | (Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide | Drug Info | [529319] | ||
Benoxaprofen | Drug Info | [537712] | |||
compound 15a | Drug Info | [527814] | |||
compound 15b | Drug Info | [527814] | |||
compound 16 | Drug Info | [527814] | |||
compound 18a | Drug Info | [527814] | |||
compound 18b | Drug Info | [527814] | |||
compound 22c | Drug Info | [527814] | |||
compound 22d | Drug Info | [527814] | |||
compound 26a | Drug Info | [527814] | |||
compound 26b | Drug Info | [527814] | |||
compound 26c | Drug Info | [527814] | |||
Nonanoic acid biphenyl-2-ylamide | Drug Info | [529319] | |||
Octanoic acid biphenyl-2-ylamide | Drug Info | [529319] | |||
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
TEP | EXP Info | ||||
Pathways | |||||
BioCyc Pathway | Isoleucine degradation | ||||
Glutaryl-CoA degradation | |||||
Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | |||||
Superpathway of cholesterol biosynthesis | |||||
Mevalonate pathway | |||||
Ketogenesis | |||||
Ketolysis | |||||
KEGG Pathway | Fatty acid degradation | ||||
Synthesis and degradation of ketone bodies | |||||
Valine, leucine and isoleucine degradation | |||||
Lysine degradation | |||||
Tryptophan metabolism | |||||
Pyruvate metabolism | |||||
Glyoxylate and dicarboxylate metabolism | |||||
Propanoate metabolism | |||||
Butanoate metabolism | |||||
Terpenoid backbone biosynthesis | |||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
Carbon metabolism | |||||
Fatty acid metabolism | |||||
NetPath Pathway | Leptin Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Butyrate Metabolism | ||||
Fatty acid Metabolism | |||||
Ketone Body Metabolism | |||||
Lysine Degradation | |||||
Valine, Leucine and Isoleucine Degradation | |||||
Pyruvate Metabolism | |||||
Propanoate Metabolism | |||||
Circadian clock | |||||
WikiPathways | Tryptophan metabolism | ||||
Synthesis and Degradation of Ketone Bodies | |||||
Metabolism of amino acids and derivatives | |||||
Fatty acid, triacylglycerol, and ketone body metabolism | |||||
Fatty Acid Beta Oxidation | |||||
References | |||||
Ref 527814 | Bioorg Med Chem Lett. 2006 Jan 1;16(1):44-8. Epub 2005 Oct 18.Synthesis and biological activity of novel 4-phenyl-1,8-naphthyridin-2(1H)-on-3-yl ureas: potent acyl-CoA:cholesterol acyltransferase inhibitor with improved aqueous solubility. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.